By Matthew Guarnaccia ( December 3, 2018, 1:22 PM EST) -- GlaxoSmithKline on Monday said it will sell its Indian consumer health unit and holdings in other Asian markets to Unilever in a £3.1 billion ($3.9 billion) deal, and at the same time announced an agreement to acquire Massachusetts-based oncology biopharmaceutical firm Tesaro Inc. for $5.1 billion, with seven firms total guiding the buyers and sellers on the tie-ups. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.